WallStSmart
RZLT

Rezolute Inc

NASDAQ: RZLT · HEALTHCARE · BIOTECHNOLOGY

$4.12
-2.37% today

Updated 2026-10-29

Market cap
$369.48M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$1 – $11
Volume
1.6M

Rezolute Inc (RZLT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201220132014201520162017201820192020202120222023202420252026
Operating cash flow$-40398.00$-1.63M$-3.17M$-7.08M$-10.49M$-13.31M$-14.11M$-15.30M$-24.17M$-20.44M$-39.62M$-44.48M$-57.37M$-69.08M$-64.64M
Capital expenditures$2000.00$11717.00$69974.00$3.16M$2.09M$407929.00$5816.00$47000.00$153000.00$153000.00$153000.00$153000.00$0.00$0.00$0.00
Depreciation$221.00$295.00$11303.00$134125.00$751254.00$1.11M$1.07M$49000.00$18000.00$13000.00$13000.00$30000.00$36000.00$31000.00—
Stock-based comp—$3.69M$1.08M$2.85M$3.76M$6.01M$5.10M$2.64M$3.32M$3.96M$3.69M$7.27M$7.36M$7.12M$14.46M
Free cash flow$-42398.00$-1.64M$-3.24M$-10.24M$-12.58M$-13.72M$-14.12M$-15.35M$-24.32M$-20.59M$-39.77M$-44.63M$-57.37M$-69.08M$-64.64M
Investing cash flow$-2000.00$185114.00$-830185.00$-3.61M$-1.45M$-195383.00$1.73M$231000.00$-101.46M$-101.46M$-101.46M$-101.46M$48.70M$-14.54M—
Financing cash flow$10500.00$1.42M$9.93M$10.04M$10.73M$13.93M$9.54M$25.00M$22.55M$51.53M$148.98M$11.57M$63.03M$107.33M—
Dividends paid———————————————
Share repurchases———————————————
Debt repayment———————————————
Net change in cash——————————$109.36M————

Frequently asked questions

How much free cash flow does RZLT generate?

RZLT produced $-64.64M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is RZLT's balance sheet healthy?

RZLT holds $10.62M in cash and equivalents against — in long-term debt, on $100.69M of shareholder equity. That debt is best read against the cash flow the business throws off each year.